#Disposable Syringes Market

[marketwire]

Disposable Syringes Market - Forecast(2024 - 2030)

Disposable Syringes Market Overview:

Disposable Syringes Market size is estimated to reach $24 billion by 2030, growing at a CAGR of 6.7% during the forecast period 2023-2030. The rising demand for injectable medications and increasing adoption of telemedicine are propelling the Disposable Syringes Market growth.

Additionally, the education and training programs for healthcare providers and end-users on the proper use, handling and disposal are creating substantial growth opportunities for the Disposable Syringes Market. As per U.S. Bureau of Labor Statistics, health education specialists and community health workers are expected to grow at a significant rate of 12% by 2031, exceeding the average growth rate for all occupations. This reflects the increasing demand for these professionals and underscores their crucial role in advancing public health and wellness. These factors positively influence the Disposable Syringes industry outlook during the forecast period.

Market Snapshot:  Disposable Syringes Market - Report Coverage:

The “Disposable Syringes Market Report - Forecast (2023-2030)” by IndustryARC, covers an in-depth analysis of the following segments in the Disposable Syringes Market.

Attribute

Segment

By Type

Safety Syringes

Conventional Syringes

Prefilled Syringes

Insulin Syringes

Others

By Syringe Size

Below 5ml

5-10ml

Above 10ml

By Application  

Therapeutic Injections

Immunization Injections

Blood Sample Collection

Others

By End-User

Diagnostics Laboratories

Hospital

Pharmaceutical Industry

Blood Banks

Veterinary

Others

By Geography

North America (U.S., Canada and Mexico)

Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand and Rest of Asia-Pacific)

South America (Brazil, Argentina, Chile, Colombia and Rest of South America)

Rest of the World (Middle East and Africa).

 

COVID-19 / Ukraine Crisis - Impact Analysis:

●        The COVID-19 pandemic has created a heightened demand for disposable syringes due to the urgent need for vaccination campaigns worldwide. Vaccination programs require massive quantities of syringes for administering vaccines, which has resulted in increased production and sales of disposable syringes.

●        The Ukraine crisis has disrupted the supply chain of disposable syringes, including procurement of raw materials, manufacturing and distribution. This can result in challenges in the availability and accessibility of disposable syringes, potentially leading to supply shortages and production delays.

Key Takeaways:

●        Fastest Growth of Rest of the World : Geographically, in the global Disposable Syringes Market share, Rest of the World is analyzed to grow with the highest CAGR of 7.3% during the forecast period 2023-2030. The growth is attributed to the rising healthcare expenditure and infrastructure development in emerging economies. Moreover, the increasing prevalence of chronic diseases and the growing demand for injectable medications are also fueling the market. In November 2021, Revital Healthcare (EPZ) Limited, a Kenyan medical supply manufacturer, announced that it had received nearly $4 million from the Bill & Melinda Gates Foundation to expand the production of auto-disable vaccine syringes. This funding allowed Revital to increase syringe production volume from approximately 72 million.

●        Therapeutic Injections is Leading the Market : According to the Therapeutic Injections Market forecast, the Therapeutic Injections held the largest market valuation of $5.9 billion in 2022 owing to the increasing prevalence of chronic diseases, rising demand for injectable medications and advancements in therapeutic treatments. Therapeutic injections are commonly used for administering medications for conditions such as diabetes, cancer, autoimmune diseases and others.

●        Prefilled Syringes to Register the Fastest Growth : In the Disposable Syringes Market analysis, the Prefilled Syringes segment is estimated to grow with the highest CAGR of 7.2% during the forecast period. The increasing demand for efficient and convenient drug delivery systems drives the adoption of prefilled syringes. These syringes come pre-loaded with a precise dosage of medication, eliminating the need for manual filling and reducing the risk of dosing errors. In May 2022, Terumo Corporation introduced a pre-fillable polymer syringe designed for low-dose applications. This innovative product provides a safe, user-friendly, and efficient treatment solution, catering to the needs of healthcare professionals and patients alike.

●         Adoption of  Injectable Medication : The demand for injectable medications is on the rise due to the increasing prevalence of chronic diseases such as diabetes, cancer, cardiovascular diseases and the growing aging population as well as advancements in therapeutic treatments. Injectable medications are preferred for their fast and effective delivery, precise dosing and ease of administration. In 2022, as per Drug Development & Delivery article, the growth of the injectable drug delivery is projected reach of $83.38 billion by 2030 which demonstrates the rising demand for efficient and convenient administration of medication through injectable routes.

●        Increasing Adoption of Telemedicine : Telemedicine enables patients to consult with healthcare professionals remotely, facilitating remote diagnosis, monitoring and prescription of medications. Disposable syringes play a crucial role in facilitating safe and convenient self-administration of injectable medications for chronic diseases like diabetes and autoimmune disorders. Syringes with their convenience, ease of use and disposable nature have become an essential tool in the telemedicine ecosystem which is driving the demand and growth of the market. In 2022, according to the NCBI report, over 57% of individuals aged 0-17 showed a high inclination towards using telehealth services and indicating a strong willingness among younger individuals to adopt telemedicine.

●        High Cost and Affordability Hamper the Market Growth : Expensive production processes, raw material costs and pricing limit accessibility, especially in resource-constrained settings and pose challenges for patients, healthcare providers and healthcare systems in procuring and using disposable syringes.This factor impedes the Disposable Syringes market growth.

Disposable Syringes Market Share (%) By Region, 2022

Product/Service launches, approvals, patents and events, acquisitions, partnerships and collaborations are key strategies adopted by players in the Disposable Syringes Market. The top 10 companies in this industry are listed below:

Baxter International Inc. (BD® 60 mL Luer syringes)

Medtronic plc (i-Port AdvanceTM)

Fresenius Kabi AG (Amicus® Extracorporeal)

Terumo Corporation (PLAJEX™ COP,  Safe'n'Sound®)

B. Braun SE (Original Perfusor® Syringes, Omnifix® Lock)

Becton, Dickinson and Company. (Ultra-Fine™, Safety-Glide™)

Novo Nordisk A/S (FlexPen®, NovoPen® 5)

Retractable Technologies, Inc. (VanishPoint®, Patient Safe®)

Henke-Sass, Wolf GmbH (HSW HENKE-JECT®– two-part, HSW HENKE-JECT® Insulin)

Nipro Corporation (Dual chamber bags PLW®, Pre-filled syringes [PFS®])

Scope of the Report: 

Report Metric

Details

Base Year Considered

2022

Forecast Period

2023–2030

CAGR

6.7%

Market Size in 2030

$24 billion

Segments Covered

Type, Syringes Size, Application, End-User and Region

Geographies Covered

North America (U.S., Canada and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia, New Zealand and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America), Rest of the World (Middle East and Africa).

Key Market Players

            Baxter International Inc.

            Medtronic plc

            Fresenius Kabi AG

            Terumo Corporation

            B. Braun SE

            Becton, Dickinson and Company.

            Novo Nordisk A/S

            Retractable Technologies, Inc.

            Henke-Sass, Wolf GmbH

            Nipro Corporation

For more Lifesciences and Healthcare Market reports, please click here

[insightslicelive]

Disposable Syringes Market Size Projection, Future Trends, Regional Outlook to 2032 | Becton Dickinson and Company, B. Braun, Baxter Int, Cardinal Health

Disposable Syringes Market Size Projection, Future Trends, Regional Outlook to 2032 | Becton Dickinson and Company, B. Braun, Baxter Int, Cardinal Health

The Global Disposable Syringes Market 2023-2032 report is a collection of details related to industry performance. Every aspect is studied in detail in the research report. The market analysis report provides comprehensive analysis of all the financial topics associated with the Disposable Syringes industry. The growth pattern seen in the Disposable Syringes industry performance over the time is…

[mi-researchreports]

Disposable Syringes Market is poised to grow at a CAGR of 5.8 % by 2027. Factors driving the Disposable Syringes Market are increasing activities by various NGOs , and  rising demand for disposable syringes.

[market-insider]

Pre and Post COVID-19 Impacts on Disposable Syringes Market

The global disposable syringes market size is anticipated to reach USD 22.81 billion by 2030, registering a CAGR of 6.12% over the forecast period, according to a new report by Grand View Research, Inc. The market is expected to expand due to the increasing adoption of safety syringes, technological advancements, increasing demand for vaccines along with growing adoption of self-administration of drugs are supporting the market growth of disposable syringes.

The COVID-19 pandemic has resulted in a significant surge in demand for emergency supplies, medical disposables, medicines, and hospital equipment. As a result of COVID-19, there has been an increase in the production of COVID-19 vaccines, resulted in rise in demand for disposable syringes. In January 2020, in the U.S alone, the Biomedical Advanced Research and Development Authority (BARDA) projected that 650 million to 850 million needles and syringes would be required to administer a vaccination. This in turn, positively impacted the market growth and is estimated to continue to be a growth driver. Moving forward, organizations like United Nations Children's Fund (UNICEF) aimed to purchase 1 billion syringes by the end of 2021 for COVID-19 vaccination operations in COVAX Facility nations. The syringes will all be of the auto-disable (AD) type, as permitted by the World Health Organization, notwithstanding the fact that the vaccines secured by the Facility may vary in their composition and storage needs. As a result, market growth is expected to accelerate in the near future.

Gain deeper insights on the market and receive your free copy with TOC now @: Disposable Syringes Market Report

Companies operating in the market are stepping up their efforts to get their products approved so that manufacturers can start mass production. One of the main areas of concern for manufacturers is the avoidance of unintentional needle stick injuries in healthcare settings. the market players are adopting various strategies, such as mergers & acquisitions, partnerships, product launches and innovations such as introduction of prefilled syringe products to strengthen their foothold in the market. Key players in the market are beefing up their R&D capabilities in order to deploy safe and simple medical practices, which is expected to enhance market growth in the near future. Some prominent players in the disposable syringes market include MEDTRONIC (Covidien); Nipro Corporation; Fresenius Kabi AG; Baxter International, Inc.; B. Braun Melsungen AG; BD.

[rr6809700]

Latest Innovations and Trends in the Sharps Containers Market

"Sharps" refers to objects with sharp points or edges that can puncture or cut the skin, such as needles, syringes, broken glass, lancets, auto-injectors, IV sets, and connecting needles. Sharps containers are specially designed to dispose of used needles and other sharp medical waste. They are designed to protect hospital workers, including sharps users and other downstream workers, from sharps injuries resulting from contact with needles and other sharp devices. Sharps disposal containers are made of rigid, puncture-resistant plastic or metal with leak-resistant sides and bottom and a tight-fitting, puncture-resistant lid with an opening for storing sharps.

[health-views-updates]

Global Biodegradable Medical Plastics Market 2024 Segmentation, Top Manufacturers, Demand, Growth, Trend, Opportunity and Forecast to 2032

The global biodegradable medical plastics market is on a strong growth trajectory, with the market size valued at USD 1.7 billion in 2023 and projected to reach USD 4.5 billion by 2032. This impressive growth reflects a compound annual growth rate (CAGR) of 11.5% over the forecast period from 2024 to 2032, driven by rising environmental concerns and the increasing demand for sustainable solutions in the healthcare sector.

Biodegradable medical plastics are designed to decompose naturally in biological environments, reducing the environmental impact associated with traditional medical waste. These plastics are used in a variety of medical applications, including surgical instruments, drug delivery systems, and packaging, offering eco-friendly alternatives to conventional materials without compromising safety or performance.

Access Free Sample Report: https://www.snsinsider.com/sample-request/4479 

Key Market Drivers

Growing Environmental Awareness: The healthcare sector has faced increasing scrutiny over the environmental impact of medical waste, particularly plastics, which contribute significantly to landfills and pollution. Biodegradable medical plastics offer a sustainable solution, breaking down into natural components and significantly reducing environmental harm. The global push for green initiatives and regulations promoting sustainability is driving demand for these materials.

Rising Demand for Sustainable Medical Products: As healthcare providers and manufacturers increasingly prioritize sustainability, the demand for biodegradable medical plastics is on the rise. Hospitals and medical device companies are adopting these materials to align with environmental standards, minimize their ecological footprint, and address the rising concerns over plastic waste from disposable medical products, including gloves, syringes, and packaging materials.

Advancements in Biodegradable Polymer Technologies: Continuous advancements in biodegradable polymer technologies are enhancing the functionality and performance of medical plastics. Innovations in materials such as polylactic acid (PLA), polyhydroxyalkanoates (PHA), and polycaprolactone (PCL) are expanding the applications of biodegradable plastics, making them suitable for a wide range of medical devices, implants, and pharmaceutical packaging. These innovations are expected to further accelerate market growth.

Regulatory Push for Eco-Friendly Materials: Governments and regulatory bodies worldwide are increasingly introducing legislation to limit the use of non-degradable plastics and encourage the adoption of eco-friendly alternatives. Regulations aimed at reducing single-use plastics and improving waste management in healthcare facilities are boosting the demand for biodegradable medical plastics. The growing compliance requirements are creating opportunities for manufacturers to invest in and expand their biodegradable product lines.

Shift Toward Circular Economy in Healthcare: The global healthcare industry is embracing the principles of the circular economy, which focuses on reducing waste and maximizing the use of resources. Biodegradable medical plastics play a crucial role in this transition by offering a more sustainable, reusable, and decomposable alternative to conventional plastics. The adoption of circular economy practices is expected to further drive the market’s expansion.

Challenges and Opportunities

While the market is growing, there are some challenges to consider, such as the higher costs associated with biodegradable medical plastics compared to traditional materials and the need for more advanced infrastructure to support the large-scale use of these products. However, increasing awareness of the long-term environmental and economic benefits of biodegradable solutions is likely to mitigate these challenges.

The ongoing development of new biodegradable materials and improved manufacturing techniques presents significant opportunities for market players. With continuous research and innovation, the production cost of biodegradable medical plastics is expected to decrease, making these materials more accessible and affordable to a broader range of healthcare providers.

Regional Insights

North America and Europe currently dominate the biodegradable medical plastics market due to their advanced healthcare systems, stringent environmental regulations, and growing focus on sustainability. The U.S. and European countries are witnessing increased adoption of biodegradable plastics in healthcare, spurred by government regulations and public pressure to reduce plastic waste.

The Asia-Pacific region is expected to experience the highest growth during the forecast period, driven by the expansion of healthcare infrastructure, rising medical device manufacturing, and growing awareness about environmental sustainability. Countries like China, Japan, and India are expected to become key markets for biodegradable medical plastics as they invest in greener solutions for healthcare.

Future Outlook

With increasing environmental awareness and a growing regulatory focus on sustainability, the biodegradable medical plastics market is expected to expand significantly over the coming decade. The projected CAGR of 11.5% from 2024 to 2032 reflects the immense potential of this market, as healthcare providers, regulators, and manufacturers work together to promote sustainable practices.

In conclusion, the biodegradable medical plastics market is poised for rapid growth, with the market size expected to rise from USD 1.7 billion in 2023 to USD 4.5 billion by 2032. As advancements in material science continue and global sustainability initiatives intensify, biodegradable plastics will become an essential part of the healthcare sector’s shift toward eco-friendly and responsible medical solutions.

[industryinsightsandanalysis]

MENA Syringes & Cannula Market: Current Analysis and Forecast (2024-2032)

According to the UnivDatos Market Insights analysis, increasing healthcare expenditure, rising prevalence of chronic diseases, growing geriatric population, government initiatives, expansion of healthcare facilities, advancements in medical procedures, and emerging as a medical tourism destination for advanced healthcare services will drive the scenario of the Syringes & Cannula market. As per their “MENA Syringes & Cannula Market” report, the market was valued at USD 1,505.79 million in 2023, growing at a CAGR of 7.29% during the forecast period from 2024 – 2032.

The healthcare industry in the MENA region is evolving rapidly due to occurrences within the region and the active actions of governments. Critical to this process is the utilization and need for Medical Devices like syringes and cannulas, which are essential in most procedures, from simple injections to complicated surgeries.

Enhanced Healthcare Expenditure and Government Initiatives

Even though most MENA countries are classified as developing, the governments are passionately trying to increase health spending. This increase in the financial share is intended to increase the number of healthcare clinics and ensure that these facilities are well-equipped with relevant products like syringes and cannulas. For instance, Vision 2030 of Saudi Arabia aims to modify the kingdom’s healthcare system, which entails upgrading the technical health infrastructure and providing adequate healthcare facilities.

Similarly, the UAE’s Ministry of Health and Prevention has stepped up efforts to improve the quality of healthcare services. Lastly, the Ministry has set regulations to license high-end products, directly affecting the syringes and cannula market. These initiatives are important as some of them act as guidelines that aim at bringing some level of uniformity in the quality of health services delivered by health practitioners and also in commercialized health services, an aspect that increases the probability of health hazards being minimized due to the safety and efficiency of the medical procedures offered.

Current Trends and Developments in the Market

Recent news includes the following events in the MENA region that are influencing the syringe and cannula market. For instance, a new regulation recently imposed in Egypt requires all syringes to be produced with safety precautions, not allowing reuse, to reduce the rate of infection. This regulation alters the existing situation regarding syringes in Egypt and becomes guidance for other countries as well.

Another new development is that Jordan has recently secured a joint venture with a multinational pharmaceutical company to set up a new industrial equipment factory for medical utensils such as syringes and cannula. Medical and health local economy in Jordan but also an attempt to gradually provide medical products in the Middle East relying on local production.

Access sample report (including graphs, charts, and figures): https://univdatos.com/get-a-free-sample-form-php/?product_id=61467

Regional Collaboration and Innovation:

The countries of the MENA region are slowly realizing the need to engage in regional cooperation in this particular sphere. Among them, the Gulf Cooperation Council (GCC) has led other countries as members to undertake healthcare projects in cooperation. These include common electronic health records and records exchange networks as well as common purchasing contracts for supplies, where aspects such as costs and quality of products like syringes and cannulas are improved.

Technological advancement is also a major factor in the regional market. For instance, researchers in Qatar are in the process of designing biodegradable cannula in a bid to deal with the issue of medical waste and safely dispose of hazardous products for the benefit of patients. This innovation not only serves as a threat to the existing products in the market but also avails the MENA region as a global significant of sustainable healthcare practices.

Difficulties and Future Prospectives:

However, some issues can act as a barrier to the delivery of health care in this region, including political instabilities in some parts and economic imbalances that might affect the uniform distribution of health care supplies. Furthermore, with the ongoing pandemic worldwide, the use of syringes and cannulas in healthcare facilities and other applications has increased, thus exerting more pressure on supply chains.

To deal with these challenges, healthcare infrastructure, strong government policies, regional cooperation, etc., need to be further enhanced. Policymakers should, therefore, shift to influencing the context to produce more positive effects on the innovation systems necessary for developing new health technologies and for training healthcare providers in the use of new medical technologies.

Conclusion:

The demand for syringes and cannulas in the MENA region is poised for significant expansion as the region remains committed to healthcare development and the application of technology. By focusing strategic investment and revising regulations and standards on regional cooperation, the region is not only responding to the emergent healthcare demand of populations today but also building a stronger and better healthcare system for the future. This willingness reflects positivism to increase health as well as illustrates that medical devices such as syringes and cannulas play an imperative part in enhancing such gains.

Contact Us:

UnivDatos Market Insights

Email - contact@univdatos.com

Contact Number - +1 9782263411

Website -www.univdatos.com

[surgikartindia0]

Top Cardiac Surgery Equipment Manufacturers in India: Innovating Healthcare

Introduction: Cardiac surgery requires precise and advanced medical instruments to ensure the highest level of care. India, being a hub for medical innovation and manufacturing, is home to many top cardiac surgery equipment manufacturers. These companies produce cutting-edge tools and technologies that meet both domestic and international standards. This article explores the leading manufacturers in India and their contributions to cardiac care.

1. Overview of the Cardiac Surgery Equipment Market in India

Brief introduction to the importance of cardiac surgery equipment.

Growth of the medical device industry in India.

Factors driving the demand for cardiac surgery equipment in India (increased cardiac cases, improved healthcare infrastructure, medical tourism).

2. Top Cardiac Surgery Equipment Manufacturers in India

a) BPL Medical Technologies

Overview of the company’s history and specialization in healthcare technology.

Range of cardiac surgery equipment offered (ECG, defibrillators, cardiac monitors).

Global partnerships and certifications.

b) Trivitron Healthcare

Pioneer in manufacturing cardiac and diagnostic devices.

Highlighting cardiac surgery equipment, including imaging devices, monitors, and surgical instruments.

Commitment to R&D and innovations in cardiac care.

c) Opto Circuits India Ltd.

Manufacturer of patient monitoring systems and critical cardiac care devices.

Specialized equipment for cardiac surgery such as blood flow meters, stents, and balloon catheters.

d) Larsen & Toubro (L&T) Medical Equipment

A leading player in surgical equipment manufacturing.

Notable contributions to cardiac surgery equipment, such as anesthesia workstations and surgical tables.

e) Hindustan Syringes & Medical Devices Ltd. (HMD)

Focus on disposable surgical instruments and syringes for cardiac procedures.

Importance of sterile instruments in cardiac surgeries.

f) Meril Life Sciences

Known for producing high-quality cardiovascular devices, including stents, heart valves, and catheter-based technologies.

Global presence and contribution to cutting-edge cardiac surgery solutions.

3. Innovation in Cardiac Surgery Equipment

Role of advanced technologies such as AI, robotics, and 3D printing in cardiac surgery tools.

India’s push towards indigenous manufacturing and the Make in India initiative.

4. Challenges and Opportunities in the Indian Market

Regulatory challenges in medical device manufacturing.

Opportunities for export growth and international collaborations.

Role of government policies and incentives in promoting the medical device industry.

5. The Future of Cardiac Surgery Equipment Manufacturing in India

Predictions for future growth and technological advancements.

Potential for Indian manufacturers to lead the global market.

Conclusion: India’s cardiac surgery equipment manufacturers are playing a crucial role in advancing healthcare, both domestically and globally. With a focus on innovation, quality, and affordability, these companies are making critical contributions to life-saving cardiac procedures. As the healthcare industry continues to grow, the future looks promising for the Indian medical device sector.

For more info:-

Cardiac Surgery Equipment Manufacturers in India

left ventricular venting manufacturer in india

[amrutatbrc1]

Intravenous Infusion Pumps Market By Product Type, By Manufacturers, By End-User And Market Trend Analysis Forecast 2033

The intravenous infusion pumps global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Intravenous Infusion Pumps Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size - The intravenous infusion pumps market size has grown strongly in recent years. It will grow from $5.71 billion in 2023 to $6.15 billion in 2024 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to advances in medical technology, aging population, home healthcare services, hospital and healthcare facility expansion, regulatory standards.

The intravenous infusion pumps market size is expected to see strong growth in the next few years. It will grow to $8.51 billion in 2028 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to increasing chronic disease burden, technological innovation, home infusion services, telehealth and remote monitoring. Major trends in the forecast period include smart infusion pumps, wireless and remote monitoring, home infusion therapy, precision medicine and personalized infusion.

Order your report now for swift delivery @ https://www.thebusinessresearchcompany.com/report/intravenous-infusion-pumps-global-market-report

The Business Research Company's reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market's historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Market Drivers - The rise in the prevalence of people with chronic pain, cancer, and diabetes is a significant driver of the demand for intravenous infusion pumps, as these pumps are commonly used to deliver pharmaceutical drugs during the treatment of these diseases. Chronic illnesses and disorders are on the rise around the world, which can be attributed to an aging population and shifts in social behavior that led to a gradual increase of these widespread and expensive long-term medical issues. Infusion pumps are used to transfer regulated doses of nutrients or drugs into a patient's body, such as chemotherapy medicines, pain relievers, antibiotics, insulin, or other hormones. For instance, in March 2022, according to the Australian Bureau of Statistics, an Australia-based autonomous statutory agency tasked with obtaining and analyzing data and making factual recommendations to local, national, and territorial governments, almost fifty percent of the population (46.6%, or 11.6 million) suffered from at least one chronic illness. Therefore, the rise in the prevalence of chronic diseases is expected to drive the growth of the intravenous infusion pumps market.

The intravenous infusion pumps market covered in this report is segmented –

1) By Product: Volumetric, Syringe, Enteral, Ambulatory, IV Disposables, Other Products 2) By Application: Chemotherapy, Diabetes, Gastroenterology, Analgesia/Pain Management, Pediatrics/Neonatology, Hematology, Other Applications 3) By End-User: Hospitals, Ambulatory Surgical Centers, Cancer Treatment Centers, Specialty Clinics, Other End Users

Get an inside scoop of the intravenous infusion pumps market, Request now for Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=3305&type=smp

Regional Insights - North America was the largest region in the intravenous infusion pumps market in 2023. Western Europe was the second-largest region in the intravenous infusion pumps market. The regions covered in the intravenous infusion pumps market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Key Companies - Major companies operating in the intravenous infusion pumps market include B. Braun Melsungen AG, Baxter International Inc., Medtronic plc, Fresenius Kabi AG, Smiths Medical Inc., Becton Dickinson and Company (BD), Terumo Corporation, F. Hoffmann-La Roche Ltd., ICU Medical Inc., IRadimed Corporation, Mindray Medical International Limited, Zyno Medical LLC, Tandem Diabetes Care Inc., Johnson & Johnson, Micrel Medical Devices SA, Boston Scientific Corporation, Pfizer Inc., Q-Core Medical Ltd., Moog Inc., Roche Diagnostics International AG, Nipro Corporation, Animas Corporation, Ypsomed Holding AG, Valeritas Inc., ZOLL Medical Corporation, Codan Medical A/S, Halyard Health Inc., InfuSystem Holdings Inc., Hospira Infusion Systems, CareFusion Corporation

Table of Contents 1. Executive Summary 2. Intravenous Infusion Pumps Market Report Structure 3. Intravenous Infusion Pumps Market Trends And Strategies 4. Intravenous Infusion Pumps Market – Macro Economic Scenario 5. Intravenous Infusion Pumps Market Size And Growth ….. 27. Intravenous Infusion Pumps Market Competitor Landscape And Company Profiles 28. Key Mergers And Acquisitions 29. Future Outlook and Potential Analysis 30. Appendix

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[healthcaremarketanalysis]

Prefilled Syringes Market worth $13.1 billion by 2030 driven by Rising Chronic Illness Rates | MarketsandMarkets™

The global Prefilled Syringes Market is expected to grow from USD 7.1 billion in 2024 to USD 13.1 billion by 2030, at a CAGR of 10.8%. Prefilled syringes are a convenient and precise medical device for delivering single doses of medication, reducing drug waste and extending product lifespan. They are increasingly adopted due to rising chronic illnesses, demand for effective drug delivery, and regulatory support for safer injection methods. Commonly used for biologics, vaccines, and other therapeutic products, these syringes enhance patient safety by minimizing errors and improving dosing accuracy. The market is expanding due to the prevalence of chronic diseases and the growing trend towards self-administration. However, challenges such as product recalls and competition from alternative drug delivery methods may impact growth. The market is driven by rising demand for biologics and biosimilars, with glass and single-chamber syringes expected to dominate. North America leads the market due to its advanced healthcare infrastructure and high demand for precise drug delivery solutions. Key players include BD, Gerresheimer AG, SCHOTT, and West Pharmaceutical Services, among others.

Download PDF Brochure:

Prefilled Syringes Market Dynamics

Drivers

· Rising target disease population

· Rapid growth in generic products

· Rising adoption of self-medication and digitalization

· Affordable cost with increased efficiency of prefilled syringes

· Technological advancements

Restraints

· Dearth of prefilled syringes with integrated safety features

Opportunities

· Growing healthcare infrastructure across emerging markets

· Surge of biologics and biosimilars in biopharma industry

· Increasing adoption of wearable drug delivery technologies

Challenges

· Availability of cheaper alternatives

· Challenges associated with manufacturing of prefilled syringes

Key Market Players

Becton, Dickinson and Company (US), Gerresheimer (Germany), SCHOTT AG (Germany), West Pharmaceutical Services, Inc. (US), Baxter International Inc (US), Ompi (Italy), Catalent, Inc. (US), Weigao Group (China), Vetter Pharma International GmbH (Germany), Nipro Corporation (Japan), Elcam Medical (Israel), YPSOMED (Switzerland), Oval Medical Technologies (UK), SHL Medical AG (Switzerland), Terumo (Japan).

Request Sample Pages

North America accounted for the largest market share of the global prefilled syringes industry, by region in the forecast period. The pre-filled syringe market is anticipated to be dominated by the North American region due to a number of factors, including an advanced healthcare infrastructure, a high prevalence of chronic diseases, and a focus on patient safety and technological innovation. Its dominant position in the market is also a result of the region’s well-established pharmaceutical industry and rising demand for practical and precise drug delivery solutions. Furthermore, continued R&D expenditures and favorable regulatory environments in North America contribute to the expansion and use of pre-filled syringes.

Recent Developments

· In October 2018, Becton, Dickinson and Company launched the BD Intevi 1mL two-step disposable autoinjector.

· In July 2020, Becton, Dickinson and Company entered into an partnership with Biomedical Advanced Research and Development Authority (BARDA) (US)

· In July 2018, Becton, Dickinson and Company acquired Teva Medical Inc. (US)

Content Source:

[researchrealmblog]

How Does Research and Development Boost Medical Injection-Molded Plastics Industry?

The medical injection-molded plastics industry has garnered $23,014.7 million revenue in 2021, and it is projected to rise at a rate of 5.7% from 2021 to 2030, to generate $37,899.5 million in 2030. It is ascribed to the rising consumption of plastic in various healthcare applications, including medical devices, mobility aids, and implant packaging.

Moreover, the surging research & development expenditure, and technological advancements in the healthcare sector propels the requirement for medical-grade injection-molded polymers.

Medical components capture the substantial industry revenue, of approx. 25% and it is further projected to follow the same trend from 2021 to 2030. It is attributed to the massive usage of high-grade plastics for medical equipment manufacturing, including catheters, syringes, containers, and medical bags.

Furthermore, the rising requirement for light and durable medical products, easy to sterilize is projected to propel the industry.

Additionally, the implants generate significant industry revenue, and their sales are projected to rise at a faster rate in the near future. It is ascribed to the rising elderly population, and the growing prevalence of dental implants, orthopedic disorders, endovascular disorders, and cardiovascular diseases.

In addition, the technological advancements in medical implants, led by extensive R&D to provide better results of medical procedures, cause industry propulsion.

Furthermore, mobility aids have experienced the highest CAGR, and it is projected to rise at the fastest rate in the future. It is ascribed to the worldwide rising elderly population, various technological advancements, and increasing healthcare expenses in developing countries.

Moreover, the rising usage of mobility aids, such as drinking aids, wheelchairs, and bath chairs, propels the market expansion.

Injection-molded plastics play a greater role in the transformation of the healthcare sector. These materials are used in the manufacturing of blood sample analysis cuvettes, pregnancy test devices, needle housing, and other medical components. It ensures their lightweight, easy sterilization, and higher affordability.

In addition, these polymers can be utilized in the production of disposable plastic syringes, and blood bags, by molding them. These plastics are used to create antibacterial contact interfaces that can kill bacteria and other pathogens, and reduce infection spread.

Moreover, these plastics can be customized to cater to the requirements of specific applications. They hold the potential to adapt to the smallest and most-delicate molds. Plastics are massively used in the production of surgical equipment, and products, including contemporary pacemakers, stents, catheters, and joint replacement systems.

North America holds the largest industry revenue, of over 40%, and it is projected to follow the same trend in the near future. It is ascribed to growing per capita income, surging healthcare costs, and a rising elderly population.

The U.S. captures a substantial share of the region-based industry, ascribed to highly advanced technology, growing demand for implantable devices, rising health awareness, healthcare policies, and government support.

APAC is projected to experience the fastest growth in the coming future, rising at a rate of over 6%. It is led by the growing application of injection-molded plastics in medical implants, components, and mobility aids.

In addition, the increasing consumer awareness of affordable medical products developed by molded products, rising concern on research and development of medical devices, and growing adoption of cutting-edge technologies in healthcare is projected to propel the industry growth.

Therefore, the medical injection molded plastics industry is projected to rise due to the increasing elderly population.

Source: P&S Intelligence

[msinsights]

Closed System Transfer Devices (CSTD) Market Size, Share, Trends, Business Growth, Top Manufacturers, End Users and Forecast to 2031

The Closed-System Transfer Devices (CSTD) Market, as analyzed by Metastat Insight, has witnessed a remarkable transformation in recent years, driven by the growing emphasis on healthcare worker safety and the need for effective drug handling procedures. These devices have emerged as critical tools, designed to minimize the risk of exposure to hazardous drugs during preparation and administration, offering a vital line of defense for healthcare professionals. 

Get Free Sample Report @ https://www.metastatinsight.com/request-sample/2746

Top Companies

Becton, Dickinson and Company, ICU Medical, Equashield, B Braun Melsungen, Needleless Corporation, Simplivia Healthcare, Corvida Medical, Yukon Medical, CODAN.

These devices offer various features and functionalities, including closed vial access systems, syringe adapters, and transfer bags, all aimed at preventing drug leakage and minimizing exposure risks during drug preparation, administration, and disposal. Additionally, advancements in technology have led to the development of innovative CSTD solutions that enhance ease of use, compatibility with existing equipment, and overall safety.  

The increasing prevalence of cancer and other chronic conditions has fueled the demand for advanced cancer treatments, including chemotherapy. However, the handling of these potent drugs presents significant risks to healthcare workers, making the adoption of closed-system transfer devices an imperative measure. By enclosing the drug transfer process, CSTDs effectively mitigate the potential for accidental exposure, minimizing the adverse health effects associated with prolonged exposure to cytotoxic agents. 

Browse Complete Report @ https://www.metastatinsight.com/report/closed-system-transfer-devices-cstd-market

Additionally, the heightened awareness of occupational hazards within the healthcare sector has played a crucial role in driving the adoption of CSTDs. Regulatory bodies and healthcare organizations worldwide have implemented stringent guidelines and protocols to safeguard the well-being of healthcare professionals. These measures have propelled the adoption of closed-system transfer devices, ensuring compliance with safety standards and mitigating potential liabilities. 

[healthcareanna]

Syringe and Needle Market Growth Drivers, Key Players, Forecast

Syringe and Needle Market Overview-

The syringe and needle market is a crucial component of the healthcare industry, facilitating precise medication administration and fluid extraction across various medical settings. The global syringe and needle market size is expected to grow USD 14.74 billion by 2032 at a CAGR of 5.90% and surpass its previous revenues over the forecast period of 2023–2032, as per a research report published by Market Research Future (MRFR). Within this market, a notable segment gaining traction is insulin pen needles. As the prevalence of diabetes continues to rise globally, the demand for efficient insulin delivery systems has intensified.

Latest Innovation on Syringe and Needle Market

1. Smart Syringes with Integrated Sensors

Recent innovations include smart syringes equipped with integrated sensors that track and record injection data, such as dosage and injection site. These devices help improve accuracy, ensure compliance, and provide valuable data for both healthcare providers and patients, enhancing overall treatment management.

2. Self-Disabling Needles

Self-disabling needle technology is addressing safety concerns by incorporating mechanisms that automatically retract or disable the needle after use. This innovation reduces the risk of needlestick injuries and cross-contamination, providing a safer option for healthcare workers and patients alike.

Insulin pen needles offer a convenient and less invasive method for diabetic patients to administer insulin compared to traditional syringes. This has led to a surge in the production and adoption of insulin pen needles by both healthcare providers and patients, driving growth in the syringe and needle market.

The Syringe and Needle Market plays a vital role in healthcare delivery, providing essential tools for medication administration, blood collection, and various medical procedures. Medical needles and syringes are ubiquitous in clinical settings, serving as indispensable components of healthcare delivery systems worldwide. Insulin pen needles, a specialized category within the market, cater to the needs of diabetic patients requiring frequent insulin injections. These fine-gauge needles, designed for use with insulin pens, offer convenience, ease of use, and reduced discomfort for individuals managing diabetes.

Syringe and Needle Market Competitive Landscape

Global Syringe and Needle Companies include

Braun Medical Inc.,

Terumo Corporation,

Albert David Ltd,

Covidien Plc,

Smiths Medical, and

Connecticut Hypodermics Inc.

Syringe and Needle Market Segmentation

The global syringes and needle market has been segmented based on type, therapeutic application, usability, and end-user. By type, the market has been segmented into Blood Collection, Intravenous, and Catheter. By therapeutic application, the market has been segmented into General Surgery and Diagnostic. By usability, the market has been segmented into disposable and reusable. By end user, the market has been segmented into Hospitals & Clinics and Home Care.

As the demand for medical needles and syringes continues to rise, Syringe and Needle Manufacturers are leveraging advancements in materials science and manufacturing technology to develop next-generation products. The Syringe and Needle Market encompasses a wide range of applications beyond insulin delivery, including vaccination, medication administration, and blood collection. Syringes and needles are essential components of routine medical procedures performed in hospitals, clinics, and home care settings. With the increasing prevalence of chronic diseases and the growing emphasis on preventive care, the demand for medical needles and syringes is expected to continue to rise, driving market expansion and innovation.

From ultra-thin insulin pen needles to safety-engineered syringes with retractable needles, manufacturers are constantly innovating to meet the evolving needs of healthcare providers and patients. Additionally, efforts are underway to enhance sustainability and reduce environmental impact through the use of recyclable materials and eco-friendly manufacturing processes.

Insulin needle pens, also known as insulin pens, combine the functionality of syringes and pens, providing a convenient and discreet method for administering insulin doses while on the go. In conclusion, the Syringe and Needle Market plays a crucial role in healthcare delivery, providing essential tools for medication administration and medical procedures. Insulin pen needles and insulin needle pens offer convenience and comfort for diabetic patients, while a diverse array of syringes and needles cater to a wide range of clinical applications. As Syringe and Needle Companies and Manufacturers continue to innovate and collaborate, the future of the market holds promise for improved patient care, safety, and efficiency.

Related Reports-

Catheters market

Medical Carts market

Healthcare Contract Manufacturing market

Population Health Management market

Clinical Trial Management System market